Eyeglasses that use SightGlass Vision Diffusion Optic Technology significantly reduced axial length and cycloplegic spherical equivalent refraction progression in children aged 6 to 7 years with myopia, the company announced in a press release.
The lens technology, which incorporates thousands of micro-dots that scatter light and reduce contrast on the retina, is intended to reduce myopia progression in children and has shown promising results in a recent analysis of clinical trial data. According to the release, myopia affects more than 2.5 billion people worldwide and is the leading cause of